Related Experiment Video
Updated: Jul 8, 2025

Intratracheal Administration of Dry Powder Formulation in Mice
Published on: July 25, 2020
A counter-swirl design concept for dry powder inhalers
Vishal Chaugule1, Larissa Gomes Dos Reis2, David F Fletcher3
1Laboratory for Turbulence Research in Aerospace and Combustion (LTRAC), Department of Mechanical and Aerospace Engineering, Monash University, Clayton Campus, Melbourne, Australia.
A novel grid-free dry powder inhaler (DPI) design uses a counter-swirl airflow to reduce drug loss. This innovative DPI design shows a 20% reduction in drug deposition compared to traditional designs.
Area of Science:
- Pharmaceutical Technology
- Aerosol Science
- Biomedical Engineering
Background:
- Dry powder inhalers (DPIs) often use swirling airflow for de-agglomeration.
- Flow-straightening grids are typically needed to minimize drug loss from lateral aerosol spreading.
- Existing DPI designs face challenges with drug deposition loss.
Purpose of the Study:
- To introduce and evaluate a novel grid-free DPI design.
- To improve aerosol flow characteristics and reduce drug deposition loss.
- To investigate the efficacy of a counter-swirl airflow mechanism.
Main Methods:
- Computational fluid dynamics (CFD) simulations.
- Particle image velocimetry (PIV) measurements.
- In-vitro deposition studies using a next-generation impactor (NGI).
Main Results:
- The counter-swirl DPI demonstrated 20% less drug deposition in the NGI induction port and pre-separator compared to a baseline DPI.
- Reduced flow-swirl in the counter-swirl DPI eliminated axial reverse flow and decreased lateral aerosol spreading.
- Modified counter-swirl designs, while preventing inlet loss, showed increased deposition due to higher flow-swirl.
Conclusions:
- The grid-free counter-swirl DPI design effectively reduces drug deposition loss.
- Counter-swirl airflow is a promising strategy for optimizing DPI performance.
- Fine particle fraction remains consistent across tested DPI designs.
Related Concept Videos
Inhaled Medications
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Design Example: Flow Through a Fire Extinguisher
The key to understanding how the...
Factors Affecting Dissolution: Particle Size and Effective Surface Area

